14-05-2013

Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...

more

06-05-2013

A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial ...

more

03-05-2013

Ben-Gurion University of the Negev researchers have proven that chronic stress increases the susceptibility to an autoimmune disease similar to multiple sclerosis, which is characterized by damage to the nervous system in the brain. The researchers, Dr. Idan Harpaz and Prof. Alon Monsonego, ...

more

27-02-2013

Researchers from the Department of Life Sciences and the National Institute for Biotechnology in the Negev at Ben-Gurion University of the Negev in collaboration with Teva pharmaceutical industries LTD. have engineered a natural immune system receptor into a promising drug candidate for the ...

more

20-02-2013

If you thought antifreeze was only something that was necessary to keep your car from freezing up in the winter, think again. Plants and animals living in cold climates have natural antifreeze proteins (AFPs) which prevent ice growth and crystallization of organic fluid matter. Without such ...

more

BGU’s Prof. Ilana Nathan and her team explore novel treatments for leukemia

19-02-2013

Ben-Gurion University of the Negev’s Prof. Ilana Nathan and her team are interested in cell death. Specifically, they investigate all sorts of chemical compounds that can kill leukemia cancer cells by taking a ‘WISE’ investigational approach. What’s unique about the research is that she and ...

more

29-11-2012

Aspireo Pharmaceuticals Limited announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion on an application for orphan medicinal product status for Aspireo’s Somatoprim (DG3173) for the treatment of acromegaly.The ...

more

Advanced Technological Solutions Ltd. selected as exclusive representative

29-11-2012

WITec, worldwide leader in nano-analytical microscopy systems, has appointed Advanced Technological Solutions Ltd. (ATSL) as its exclusive distributor in Israel. From now on ATSL will support WITec’s market entry and promote the full product line of high-resolution SNOM, AFM and Raman Imaging ...

more

28-11-2012

Prof. Amir Sagi from Ben-Gurion University of the Negev (BGU) participated in a ceremony marking the realization of an agreement between the Israeli Tiran Group and Green Advances, a Vietnamese company, to advance aquaculture in Vietnam using BGU biotechnology to change the sex of prawns and ...

more

27-11-2012

r. Raz Zarivach of the Department of Life Sciences and a member of the National Institute for Biotechnology in the Negev was recently declared an EMBO Young Investigator. He is one of four Israelis to receive this honor among a group of 22 young researchers from around the world. Zarivach is ...

more